Assessing the Quality of Life, Coping Strategies, Anxiety and Depression Levels in Patients with Long-COVID-19 Syndrome: A Six-Month Follow-Up Study
Authors:
- Adrian Vasile BotaAdrian Vasile Bota
- Felix BratosinFelix Bratosin
- Iulia BogdanIBIulia Bogdan
- Susa Septimiu-RaduSSSusa Septimiu-Radu
- Adrian Cosmin IlieAIAdrian Cosmin Ilie
- Sonia-Roxana BurticSBSonia-Roxana Burtic
- David Vladut RazvanDRDavid Vladut Razvan
- Raluca TudorRTRaluca Tudor
- Mirela Florica IndriesMIMirela Florica Indries
- Andrei Nicolae CsepACAndrei Nicolae Csep
- Ariadna Petronela FildanAFAriadna Petronela Fildan
- Camelia Melania BudeaCBCamelia Melania Budea
Open Access
Abstract
This longitudinal study investigates the psychosocial effects of long-COVID Syndrome, a domain still not extensively researched. It specifically evaluates the quality of life, coping mechanisms, anxiety and depression levels in COVID-19 survivors, differentiating between those with and without long-COVID Syndrome. Conducted at the Victor Babes Hospital for Infectious Diseases and Pulmonology in Timisoara, Romania, the study utilized a cohort of patients diagnosed with mild to moderate COVID-19. The following standardized tools: WHOQOL-BREF for quality of life, COPE-60 for coping strategies, and the Hospital Anxiety and Depression Scale (HADS), were employed for the assessment. The sample consisted of 86 patients displaying persistent post-acute symptoms and 432 asymptomatic patients at the 6-month post-discharge mark. Patients with frequent post-acute symptoms reported significantly higher levels of fatigue (8.2 ± 1.4), cognitive difficulties (7.5 ± 1.6), and respiratory challenges (7.8 ± 1.3), along with a markedly lower overall quality of life (7.0 ± 1.5) compared to their asymptomatic counterparts. HADS scores revealed elevated depression (6.8 ± 1.9) and anxiety (7.1 ± 2.3) in the symptomatic group. Quality of life, as evaluated through the use of WHOQOL-BREF, showed lower scores in the symptomatic cohort across physical (58.8 ± 15.8), mental (56.3 ± 16.4), and social domains (50.2 ± 17.5). COPE-60 findings indicated a higher prevalence of disengagement (56.4%) and emotion-focused coping strategies (61.8%) in the symptomatic group, in contrast to 30.1% and 37.0%, respectively, in the asymptomatic group. The study highlights that long-COVID Syndrome significantly deteriorates the quality of life and is associated with increased depression and anxiety levels. The prevalent use of disengagement and emotion-focused coping strategies among patients with persistent symptoms suggests a need for enhanced psychosocial support tailored to this subgroup.Keywords
This publication has 30 references indexed in Scilit:
- Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare ProfessionalsArchives of Medical Research, 2021
- Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patientsBritish Journal of Anaesthesia, 2021
- mRNA vaccines for COVID-19: what, why and howInternational Journal of Biological Sciences, 2021
- Generic and Respiratory-Specific Quality of Life in Non-Hospitalized Patients with COVID-19Journal of Clinical Medicine, 2020
- Is patient blood management cost-effective? Comment on Br J Anaesth 2020British Journal of Anaesthesia, 2020
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategiesInternational Journal of Antimicrobial Agents, 2020
- Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patientsSupportive Care in Cancer, 2019
- Assessing quality of life using WHOQOL-BREF: a cross-sectional study on the association between quality of life and neighborhood environmental satisfaction, and the mediating effect of health-related behaviorsBMC Public Health, 2018
- Gender differences in stress and coping stylesPersonality and Individual Differences, 2004
- You want to measure coping but your protocol’ too long: Consider the brief copeInternational Journal of Behavioral Medicine, 1997